NCT04565067 Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04564287 An Observational Study of Neurologic Function After COVID-19 Infection Status COMPLETED Phase N/A
NCT04564040 A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole Status COMPLETED Phase PHASE1
NCT04561193 Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19) Status COMPLETED Phase N/A
NCT04555005 Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19 Status COMPLETED Phase NA
NCT04552951 Effect of Vitamin D on Morbidity and Mortality of the COVID-19 Status UNKNOWN Phase PHASE4
NCT04552366 A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults Status COMPLETED Phase PHASE1
NCT04551911 Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 Status COMPLETED Phase PHASE2
NCT04551547 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 Status COMPLETED Phase PHASE1/PHASE2
NCT04550338 Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure Status WITHDRAWN Phase PHASE3
NCT04549337 Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19 Status COMPLETED Phase NA
NCT04547257 Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 Status ACTIVE_NOT_RECRUITING Phase NA
NCT04547140 Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) Status TERMINATED Phase PHASE2
NCT04547127 A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) Status COMPLETED Phase PHASE2
NCT04546581 Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) Status COMPLETED Phase PHASE3
NCT04545749 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine Status COMPLETED Phase PHASE1